Pharmacology

Australian start-up Snoretox pitched the injectable therapy during the 2025 KC Animal Health Corridor Summit in Kansas City, Missouri.

Gamrozyne is the first generic version of Zactran, a pioneer product.

Michael W. Dryden, DVM, MS, PhD, DACVM (Parasitology), delivered a keynote address focused on canine heartworm disease on day 2 of the 2025 Fetch dvm360 Conference in Kansas City, Missouri.

The company voluntarily recalled its 2 lots of product due to potential health risks.

Regulatory approval from animal health authorities is still required before the vaccine can be made commercially available.

The JAK inhibitor will be available to veterinarians and dog owners in the United Kingdom by the end of Q3 2025.

Nostrum Laboratories cannot guarantee the safety of Sucralfate Tablets USP 1 gram manufactured after June 2023.

This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which received FDA clearance earlier this month

Fluralaner for extended-release injectable suspension (Bravecto Quantum) is also indicated for treatment of lone star tick in dogs.

TruCan Ultra CIV H3N2/H3N8 will broadly protect canine patients from canine influenza.

The funding will support Gallant’s treatment for refractory feline chronic gingivostomatitis, which is in development.

Cefovecin Sodium for Injection is sponsored by Qilu Animal Health Products Co.

ELIAS Cancer Immunotherapy was combined with chemotherapy in a study with results presented at the 2025 ACVIM Forum.

Sirolimus delayed-release tablets (felycin-CA1; PRN Pharmacal) have conditional approval from the FDA.

Elanco Animal Health’s ilunocitinib tablet (Zenrelia) was approved by the FDA in 2024.

The latest canine otitis externa medication is the only FDA-approved, 1-dose, in-clinic treatment for Pseudomonas aeruginosa and other pathogens.

Royal Canin is highlighting the importance of a personalized health plan based on each pets' unique needs with these products and designated day for awareness

Dechra’s Otiserene is a single-dose, long-acting product that utilizes marbofloxacin

Visible particulate matter was observed in 2 products containing dexmedetomidine hydrochloride injection 0.5 mg/mL for dogs and cats.

The nutraceutical 4CYTE Epiitalis Forte Dog was previously only available abroad and is now distributed domestically by epiq Animal Health and Interpath Global.

OST-HER2 could be a frontline treatment for dogs and humans

The STAY study is investigating LOY-002, a therapy designed by Loyal to extend healthy lifespans in canines

The FDA has approved the new indication for Zoetis' Simparica Trio

Treating separation anxiety requires behavioral modification and medication, but which drug should you choose?

The entire hive can be treated for common bacterial diseases

Current levels of pain management administration by dairy producers and veterinarians in Europe and North America are low.

Felixvet has introduced a carprofen therapy with the same therapeutic benefits as Rimadyl

Communications expert Wendy S. Myers provides scripts for confident client conversations

Zoetis has launched its’ 0.5 mL dose for intranasal Vanguard B